Race as a Ghost Variable in (White) Opioid Research
Bibliographic Data
| ID | 11261544 |
|---|---|
| Authors | H Hansen (0000-0003-0569-1392, New York University, corresponding author), Caroline Mary Parker (0000-0002-0817-2494, University of Manchester), Caroline Parker (University of Manchester), Jules Netherland (Office of Academic Engagement, Drug Policy Alliance, New York, NY, USA) |
| Year | 2020 |
| Volume | 45 |
| Issue | 5 |
| Pages | 848-876 |
| Publication date | 2020-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science Technology & Human Values (JOURNAL) |
| Journal identifiers | ISSN: 0162-2439 • E-ISSN: 1552-8251 |
| Publisher | SAGE Publications (PUBLISHER • US) |
| DOI | 10.1177/0162243920912812 |
| OpenAlex | W3014547839 |
| Language | EN |
| Citations received | 19 |
| References cited | 57 |
This paper traces the unspoken, implicit white racial logic of the brain disease model of addiction, which is based on seemingly universal, disembodied brains devoid of social or environmental influences. In the United States, this implicit white logic led to “context-free” neuroscience that made the social hierarchies of addiction and its consequences invisible to, and thus exacerbated by, national policies on opioids. The brain disease model of addiction was selectively deployed among the white middle-class population that had long accessed narcotics and pharmaceutical treatments for narcotics disorders from biomedical clinics, as opposed to from illegal sources subject to law enforcement. In turn, new treatments for opioid addiction were racially marketed to the same white clientele to which newly patented opioid analgesics were marketed, tapping into a circumscribed but highly lucrative consumer base that has long benefited from a legally protected, racially segregated safe space for white narcotics consumption. The connecting thread for the contemporary white opioid “crisis,” therefore, is white race as a ghost variable in addiction neuroscience and in its pharmaceutical and biotechnological translation
Addiction · Context (archaeology · Criminology · Environmental health · Opioid · Population · Psychiatry · Race (biology · Sociology · White (mutation · Gender Studies · History · Medicine · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Psychology · Substance Abuse Treatment and Outcomes
The ‘Ghost in the Shell’ of NHS Patient Data Policies
Transnationalizing Critical Drug Studies
The Psychological Anthropology of Mental Health and Psychiatric Treatment
Coalition-Making and the Practice of Feminist STS in the time of Covid-19
The New Opioid Novel
Media framings of the role of genomics in “addiction” in the United States from 2015 to 2019
AI and the Complexity of Pain
An Enquiry Into Modes of Non-Existence
Association of Patient Race and Ethnicity With Differences in Opioid Prescribing by Primary Care Physicians for Older Adults With New Low Back Pain
A National Portrait of Public Attitudes toward Opioid Use in the US
How opioids became “safe”
Race, rurality and geographic accessibility to medication for opioid use disorder in the U.S
Anesthetized Gladiators
The social organization of opioid policies and their implications for people with chronic pain and clinicians
Sensing Race as a Ghost Variable in Science, Technology, and Medicine
Auras of Detection
Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives
Differences in Determinants
Solidarity
Addiction Trajectories
Blood Sugar
Pharmaceutical Reason
The American Disease, Origins Of Narcotic Control
Breathing Race into the Machine
Addiction Is a Brain Disease, and It Matters
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments
Drug Dependence, a Chronic Medical Illness
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
Ghostly Matters
Medicating Race
Enforcing Freedom
Bridgework
Catching Our Breath
The Right Patients for the Drug
Toward a critical neuroscience of ‘addiction’
How crack found a niche in the American ghetto
White opioids
Addiction as accomplishment
Supervised consumption rooms
Treating Addiction or Reducing Crime? Methadone Maintenance and Drug Policy Under the Nixon Administration
Exploiting Race in Drug Development
Assisted Technologies of Social Reproduction
Racializing Drug Design
The Promotion and Marketing of OxyContin
The New Jim Crow
Habits
Discovering Addiction
The War on Drugs That Wasn’t
The Structure of Racism in Color-Blind, "Post-Racial" America
The plastic brain
Life of the mind
Shifting blame
From White Bullets to Black Markets and Greened Medicine
Opiates for the masses
Disciplining Addictions
| Unique citing works | 19 |
|---|---|
| Citations per year | 3,17 |
| Citation span | 2020 - 2026 (7) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 17 |